Press briefing on PRAC conclusions on signal of thromboembolic events with COVID-19 Vaccine Janssen

• Date:
  Tuesday, 20 April 2021
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

EMA is holding a virtual press briefing on the conclusion of the evaluation of a safety signal with Jcovden (previously COVID-19 Vaccine Janssen) relating to cases of thromboembolic events by EMA’s safety committee, the Pharmacovigilance Risk Assessment Committee (PRAC), on 20 April 2021.

Speakers:

• Ms Emer Cooke (Executive Director)
• Dr Sabine Straus (Chair of PRAC)
• Dr Peter Arlett (Head of Data Analytics and Methods Task Force).

The press briefing will be moderated by Ms Marie-Agnes Heine (Head of Communication).

The press briefing will be held in English.

Video recording